Brian Daniels
Member of the Board and member of the Research & D
Healthcare
Novo Nordisk
Belarus
Biography
Dr Daniels is senior advisor with the Boston Consulting Group and venture partner with Venture Management, LLC, both in the US. Dr Daniels has a M.D. from Washington University, St. Louis, US (1987) and a B.S. in Life Sciences from Massachusetts Institute of Technology, Cambridge, US (1981). Dr Daniels also has a M.A. in Metabolism and Nutritional Biochemistry from Massachusetts Institute of Technology, Cambridge, US (1981). Dr Daniels was first elected to the Board of Novo Nordisk A/S in 2016 and has most recently been re-elected in March 2017. His term as a board member expires in March 2018. In March 2017, the Board of Directors of Novo Nordisk A/S assessed that Dr Daniels is regarded as an independent board member as defined in Section 3.2.1 of the Recommendations on Corporate Governance designated by Nasdaq Copenhagen.
Research Interest
Venture Mangement, Healthcare, Pharmaceuticals, Nutritional Biochemistry etc.
